To treat or not to treat? Adjuvant chemotherapy in 46 patients with stage IB lung squamous cell carcinoma: a real-world matched analysis
ACT may not confer significant survival benefits in resected stage IB SqCC, with comparable disease-free and overall survival outcomes observed between treatment and observation groups.
Authors
- Bin Liang (ORCID: https://orcid.org/0000-0001-9131-5478)
- Jing Yang (ORCID: https://orcid.org/0000-0001-9882-4697)
- Zhaofeng Gao (ORCID: https://orcid.org/0000-0002-6960-465X)
- Leilei Shen
- Tao Zhang (ORCID: https://orcid.org/0000-0003-0562-6865)
- Kai Zhao (ORCID: https://orcid.org/0000-0002-9662-375X)
- Chaoyang Liang (ORCID: https://orcid.org/0000-0002-1706-8613)
- Tingting Fu (ORCID: https://orcid.org/0000-0001-8173-8389)
- Lianbin Zhang (ORCID: https://orcid.org/0000-0003-1677-146X)
- Juntang Guo
Institutions
- Nankai University (CN)
- People's Liberation Army No. 150 Hospital (CN)
- Hubei 672 Orthopedics Hospital of Traditional Chinese Medicine and Western Medicine (CN)
- Hainan 301 Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-10-08
- DOI
- https://doi.org/10.3389/fonc.2025.1647649
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00